[
  {
    "objectID": "index.html",
    "href": "index.html",
    "title": "Education",
    "section": "",
    "text": "I earned my Ph.D. in Biostatistics from The Ohio State University in 2023. My research focuses on multistate transition models and causal inference, with a strong emphasis on healthcare applications.\n\n\nEducation\n\nPhD in Biostatistics, The Ohio State University, Columbus, OH, USA, 2023\nMS in Biostatistics, Tulane University, New Orleans, LA, USA, 2017\nBS in Pharmaceutical Formulation，China Pharmaceutical University, Nanjing, China, 2015\n\n\n\nExperience\nUniversity Hospitals Rainbow Babies & Children’s Hospital, Cleveland, OH\nBiostatistician, Aug 2023 - Present\n\n\nPublication\n\nZhu Y, Brock G, Li L. Uniformization and bounded Taylor series in Newton–Raphson method improves computational performance for a multistate transition model estimation and inference. Statistical Methods in Medical Research. 2024;0(0). doi:10.1177/09622802241283882\nDonneyong, M. M., Zhu, Y., Zhang, P., Li, Y., Hunold, K. M., Chiang, C., ... & Li, L. (2023). A comprehensive assessment of statin discontinuation among patients who concurrently initiate statins and CYP3A4‐inhibitor drugs; a multistate transition model. British Journal of Clinical Pharmacology, 89(7), 2076-2087.\nZhu, Y., Chiang, C. W., Wang, L., Brock, G., Milks, M. W., Cao, W., ... & Li, L. (2021). A multistate transition model for statin‐induced myopathy and statin discontinuation. CPT: Pharmacometrics & Systems Pharmacology, 10(10), 1236-1244."
  },
  {
    "objectID": "Blog/posts/post-with-code/index.html",
    "href": "Blog/posts/post-with-code/index.html",
    "title": "Venn diagram based on size",
    "section": "",
    "text": "This blog provides an example for using the euler() function from the eulerr package. An extra rectangle is added out of the euler diagram to show none of events from all sets happened.To make things easier, an R shiny website is created for people using it without any knowledge of R.\n\nfit &lt;- euler(c(\n        A = 10, #only A\n        B = 15, #only B\n        C = 20, #only c\n        \"A&B\" = 5, #only AB\n        \"A&C\" =6, #only AC\n        \"B&C\" = 7, #only BC\n        \"A&B&C\" = 4 #only ABC\n      ))\n      \n      # Plot Euler diagram using ggplot2\n      p &lt;- plot(fit, quantities = TRUE)\n      # Print the plot\n      print(p)\n      \n      # Add a rectangle to represent \"None of those happen\"\n      grid.rect(gp = gpar(lwd = 2, col = \"black\", fill = NA))\n      grid.text(\n        label = paste0(\"None:\", 3),  # None of happen\n        x = 0.9, y = 0.9, gp = gpar(col = \"black\", fontsize = 12, fontface = \"bold\")\n      )"
  },
  {
    "objectID": "Blog/posts/welcome/index.html",
    "href": "Blog/posts/welcome/index.html",
    "title": "KM plot based on R package survminer",
    "section": "",
    "text": "This blog offers a comprehensive guide on using the ggsurvplot() function from the survminer package, with a focus on utilizing various arguments to customize and enhance the survival plots.”\n\nlibrary(\"survminer\")\nrequire(\"survival\")\nfit &lt;- survfit(Surv(time, status) ~ sex, data = lung)\n\n\nggsurvplot(\n  fit,                     # survfit object\n  data = lung,  # data\n  palette = c(\"black\", \"black\"), # color for each group\n  linetype =c(4,1), # linetype for each group\n  risk.table = TRUE,       # show risk table.\n  pval = TRUE,             # show p-value of log-rank test.\n  pval.coord= c(800, 0.85), # p value location\n  #conf.int = TRUE,         # show confidence intervals \n  xlim = c(0,1000),        # limit for X axis\n  # survival estimates.\n  break.time.by =100 ,     # break X axis in time intervals by 500.\n  xlab=\"Time\",\n  ylab=\"Survival probability\",\n  legend.title = \"\",\n  legend.labs = c(\"Female\", \"Male\"), #legend label\n  #ggtheme = theme_minimal(), # customize plot and risk table with a theme.\n  risk.table.y.text.col = T, # colour risk table text annotations.\n  risk.table.y.text = TRUE, # show bars instead of names in text annotations\n  risk.table.title= \"Number\"\n  # in legend of risk table\n)"
  },
  {
    "objectID": "Blog/index.html",
    "href": "Blog/index.html",
    "title": "Yuxi Zhu",
    "section": "",
    "text": "Venn diagram based on size\n\n\n\n\n\n\n\ncode\n\n\nanalysis\n\n\n\n\n\n\n\n\n\n\n\nNov 21, 2024\n\n\nYuxi Zhu\n\n\n\n\n\n\n  \n\n\n\n\nKM plot based on R package survminer\n\n\n\n\n\n\n\nCode\n\n\n\n\n\n\n\n\n\n\n\nNov 10, 2024\n\n\nYuxi Zhu\n\n\n\n\n\n\nNo matching items"
  },
  {
    "objectID": "Publication.html",
    "href": "Publication.html",
    "title": "Multistate transition models",
    "section": "",
    "text": "Multistate transition models\n\nZhu Y, Brock G, Li L. Uniformization and bounded Taylor series in Newton–Raphson method improves computational performance for a multistate transition model estimation and inference. Statistical Methods in Medical Research. 2024;0(0). doi:10.1177/09622802241283882\nDonneyong, M. M., Zhu, Y., Zhang, P., Li, Y., Hunold, K. M., Chiang, C., ... & Li, L. (2023). A comprehensive assessment of statin discontinuation among patients who concurrently initiate statins and CYP3A4‐inhibitor drugs; a multistate transition model. British Journal of Clinical Pharmacology, 89(7), 2076-2087.\nZhu, Y., Chiang, C. W., Wang, L., Brock, G., Milks, M. W., Cao, W., ... & Li, L. (2021). A multistate transition model for statin‐induced myopathy and statin discontinuation. CPT: Pharmacometrics & Systems Pharmacology, 10(10), 1236-1244."
  },
  {
    "objectID": "index.html#education",
    "href": "index.html#education",
    "title": "Yuxi Zhu",
    "section": "Education",
    "text": "Education\n\nPhD in Biostatistics, The Ohio State University, Columbus, OH, USA, 2023\nMS in Biostatistics, Tulane University, New Orleans, LA, USA, 2017\nBS in Pharmaceutical Formulation，China Pharmaceutical University, Nanjing, China, 2015"
  },
  {
    "objectID": "index.html#multistate-transition-models",
    "href": "index.html#multistate-transition-models",
    "title": "Education",
    "section": "Multistate transition models",
    "text": "Multistate transition models\n\nZhu Y, Brock G, Li L. Uniformization and bounded Taylor series in Newton–Raphson method improves computational performance for a multistate transition model estimation and inference. Statistical Methods in Medical Research. 2024;0(0). doi:10.1177/09622802241283882\nDonneyong, M. M., Zhu, Y., Zhang, P., Li, Y., Hunold, K. M., Chiang, C., ... & Li, L. (2023). A comprehensive assessment of statin discontinuation among patients who concurrently initiate statins and CYP3A4‐inhibitor drugs; a multistate transition model. British Journal of Clinical Pharmacology, 89(7), 2076-2087.\nZhu, Y., Chiang, C. W., Wang, L., Brock, G., Milks, M. W., Cao, W., ... & Li, L. (2021). A multistate transition model for statin‐induced myopathy and statin discontinuation. CPT: Pharmacometrics & Systems Pharmacology, 10(10), 1236-1244."
  },
  {
    "objectID": "index.html#experience",
    "href": "index.html#experience",
    "title": "Yuxi Zhu",
    "section": "Experience",
    "text": "Experience\nUniversity Hospitals Rainbow Babies & Children’s Hospital|Biostatistician|Aug 2023 - Present"
  },
  {
    "objectID": "index.html#publication",
    "href": "index.html#publication",
    "title": "Yuxi Zhu",
    "section": "Publication",
    "text": "Publication\n\nZhu Y, Brock G, Li L. Uniformization and bounded Taylor series in Newton–Raphson method improves computational performance for a multistate transition model estimation and inference. Statistical Methods in Medical Research. 2024;0(0). doi:10.1177/09622802241283882\nDonneyong, M. M., Zhu, Y., Zhang, P., Li, Y., Hunold, K. M., Chiang, C., ... & Li, L. (2023). A comprehensive assessment of statin discontinuation among patients who concurrently initiate statins and CYP3A4‐inhibitor drugs; a multistate transition model. British Journal of Clinical Pharmacology, 89(7), 2076-2087.\nZhu, Y., Chiang, C. W., Wang, L., Brock, G., Milks, M. W., Cao, W., ... & Li, L. (2021). A multistate transition model for statin‐induced myopathy and statin discontinuation. CPT: Pharmacometrics & Systems Pharmacology, 10(10), 1236-1244."
  }
]